Economy
WIPO Global Innovation Index 2025
Why in news? The World Intellectual Property Organization (WIPO) released its Global Innovation Index 2025, ranking 139 economies. India rose to 38th ...
The day’s current affairs covered in full — the terms, names and facts UPSC actually asks about, in six languages.
Why in news? The World Intellectual Property Organization (WIPO) released its Global Innovation Index 2025, ranking 139 economies. India rose to 38th ...
Why in news? The Directorate of Revenue Intelligence (DRI), India’s premier anti‑smuggling agency under the Central Board of Indirect Taxes and Cu...
Why in news? Debate has arisen over whether India should liberalise dairy imports as part of free trade negotiations. Farmers’ organisations argue t...
Why in news? Recent data show that a large share of India’s outward foreign direct investment (OFDI) is routed through a handful of low‑tax jurisd...
Why in news? The term “involution” has been used to describe recent price wars in China’s electric vehicle (EV) industry, where intense competit...
Why in news? The United States recently imposed 50% tariffs on a range of Indian goods, reigniting debate on India’s high import duties. The U.S. ha...
Why in news? Bhadohi’s hand‑knotted carpet industry — which accounts for more than 60% of India’s carpet exports — is reeling after the Unit...
Why in news? The National Statistical Office (NSO) announced that it will conduct two important surveys between July 2026 and June 2027: the All India...
Why in news? The rapid growth of decentralised finance has raised concerns about its potential use for terror financing and money laundering. Experts ...
Why in news? Launched during the 2024 India–UK Economic and Financial Dialogue, the UKIIFB marked its first anniversary with a report recommending p...
Why in news? India is preparing to roll out the next phase of its Goods and Services Tax (GST). The proposed “GST 2.0” seeks to collapse multiple ...
Why in news? India’s pharmaceutical industry supplies a large share of the world’s generic medicines. In September 2025 policymakers called for us...
